Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $383K 9,258 sh | Jan 16, 2026 |
| 4 | Ruttenberg David W.Director | Open-market sale · 10b5-1 plan | SELL | $145K 12.5K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $448K 10.7K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $479K 11.5K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $348K 8,467 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 3 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 2,813 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 3 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Grant or award · 10b5-1 plan | A | — 37.2K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 2 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $93K 5,893 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 2 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $68K 14.6K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 1 | Peer AndrewVP, Corporate Controller & CAO | Open-market sale · 10b5-1 plan | SELL | $15K 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Peer AndrewVP, Corporate Controller & CAO | Option exercise · 10b5-1 plan | M | $4,270 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 62.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 2,678 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 62.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Inukonda RaviCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | — 1,017 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Peer AndrewVP, Corporate Controller & CAO | Option exercise · 10b5-1 plan | M | — 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $94K 2,678 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Inukonda RaviCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | $7,790 1,017 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Option exercise · 10b5-1 plan | M | — 3,054 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 250.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | D'Amico AndrewDirector | Option exercise · 10b5-1 plan | M | $20K 200 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $25K 1,407 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Grant or award · 10b5-1 plan | A | — 44.7K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 1,407 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $28K 2,813 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Grant or award · 10b5-1 plan | A | — 300.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 250.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $2,446 321 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 5,893 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 14.6K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 56 | Versaci Vincent WTrustee | Open-market purchase | BUY | $11K 1,336 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 56 | McNally Kevin JosephTrustee | Open-market purchase | BUY | $5,135 634 sh | Jan 15, 2026 traded Jan 14, 2026 |